The strategy of long-term low-dose supplementation also enables effective treatment of hypovitaminosis D. The doses used (500 or 1000 IU) increased serum 25(OH)D concentrations and were sufficient to decrease PTH concentrations (p < 0.001), thereby preventing bone decalcification. The gene discussed is PTH; the disease is rickets.